Sihoun Hahn MD
Clinical Biochemical Genetics, Clinical Genetics
Professor, Pediatrics, University of Washington School of Medicine
Join to View Full Profile
4800 Sand Point Way NeM/S B-6594Seattle, WA 98105
Phone+1 206-987-3012
Fax+1 206-987-5329
Dr. Hahn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Korea University College of MedicineClass of 1983
Certifications & Licensure
WA State Medical License 2006 - 2027
MN State Medical License 2003 - 2007
American Board of Medical Genetics and Genomics Clinical Biochemical Genetics- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Publications & Presentations
PubMed
- Corrigendum to "Home infusion experience in patients with Pompe disease receiving avalglucosidase alfa during three clinical trials" [Molecular Genetics and Metabolism...Jordi Díaz-Manera, Derralynn Hughes, Sevim Erdem-Özdamar, Céline Tard, Anthony Béhin
Molecular Genetics and Metabolism. 2025-03-01 - 9 citationsExpanded Newborn Screening Using Genome Sequencing for Early Actionable Conditions.Alban Ziegler, Carrie Koval-Burt, Denise M Kay, Sharon F Suchy, Amber Begtrup
JAMA. 2025-01-21 - Advancing Newborn Screening in Washington State: A Novel Multiplexed LC-MS/MS Proteomic Assay for Wilson Disease and Inborn Errors of Immunity.Claire Klippel, Jiwoon Park, Sean Sandin, Tara M L Winstone, Xue Chen
International Journal of Neonatal Screening. 2025-01-10
Press Mentions
Seattle Children’s Research Division: Celebrating 15 Years of InnovationNovember 12th, 2021- Pilot Study Explores Screening of Newborns for Wilson’s DiseaseFebruary 28th, 2024
Grant Support
- Development of a Multiplex Proteomics Assay for High-Throughput Newborn Screening of a New Set of Treatable Neonatal DiseasesSEATTLE CHILDREN'S HOSPITAL2023–2027
- Development of a Multiplex Proteomics Assay for High-Throughput Newborn Screening of a New Set of Treatable Neonatal DiseasesSEATTLE CHILDREN'S HOSPITAL2023–2027
- Development of a Multiplex Proteomics Assay for High-Throughput Newborn Screening of a New Set of Treatable Neonatal DiseasesSEATTLE CHILDREN'S HOSPITAL2023–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
